Consolidated Statement Of Income

Mochida Pharmaceutical Co.,Ltd. - Filing #7729392

Concept 2017-04-01 to
2017-12-31
2016-04-01 to
2016-12-31
Consolidated statement of income
Statement of income
Net sales
83,730,000,000 JPY
73,037,000,000 JPY
Cost of sales
40,434,000,000 JPY
28,435,000,000 JPY
Operating expenses
Selling, general and administrative expenses
31,071,000,000 JPY
31,515,000,000 JPY
Operating expenses
Gross profit (loss)
43,296,000,000 JPY
44,602,000,000 JPY
Operating profit (loss)
12,209,000,000 JPY
13,088,000,000 JPY
Net sales
Ordinary profit (loss)
12,496,000,000 JPY
13,328,000,000 JPY
Non-operating income
330,000,000 JPY
300,000,000 JPY
Dividend income
214,000,000 JPY
193,000,000 JPY
Interest income
2,000,000 JPY
6,000,000 JPY
Extraordinary income
194,000,000 JPY
0 JPY
Cost of sales
Non-operating income
Other
113,000,000 JPY
100,000,000 JPY
Selling, general and administrative expenses
Non-operating expenses
Interest expenses
3,000,000 JPY
8,000,000 JPY
Other
7,000,000 JPY
19,000,000 JPY
Non-operating expenses
43,000,000 JPY
60,000,000 JPY
Extraordinary losses
26,000,000 JPY
20,000,000 JPY
Gross profit
Profit (loss) before income taxes
12,665,000,000 JPY
13,308,000,000 JPY
Extraordinary income
Gain on sale of non-current assets
194,000,000 JPY
0 JPY
Extraordinary losses
Income taxes
3,394,000,000 JPY
3,512,000,000 JPY
Profit (loss)
9,270,000,000 JPY
9,795,000,000 JPY
Profit (loss) attributable to owners of parent
9,270,000,000 JPY
9,795,000,000 JPY
Other comprehensive income
Valuation difference on available-for-sale securities
1,873,000,000 JPY
873,000,000 JPY
Remeasurements of defined benefit plans, net of tax
109,000,000 JPY
268,000,000 JPY
Other comprehensive income
1,982,000,000 JPY
1,141,000,000 JPY
Profit attributable to
Comprehensive income
11,252,000,000 JPY
10,936,000,000 JPY
Comprehensive income attributable to
Comprehensive income attributable to owners of parent
11,252,000,000 JPY
10,936,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.